Medicare Enrolled
Dr. Saritha Dodla, M.D.
Cardiovascular Disease · Fort Worth, TX
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dodla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dodla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dodla
Dr. Saritha Dodla is a cardiovascular disease specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dodla performed 5,561 Medicare services across 3,775 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dodla received a total of $2,499 from 26 pharmaceutical and/or device companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dodla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in TX
$2,499 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,561
Medicare services
Top 13% in TX for cardiovascular disease
3,775
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~293 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
793 | $60 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
758 | $88 | $200 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
639 | $135 | $698 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
266 | $38 | $150 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
265 | $10 | $70 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
229 | $39 | $180 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
195 | $18 | $71 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
184 | $43 | $150 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
183 | $31 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
165 | $115 | $320 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
159 | $23 | $94 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
153 | $10 | $100 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
103 | $143 | $785 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
89 | $63 | $272 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
88 | $21 | $90 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
83 | $357 | $488 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
81 | $339 | $1,200 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
77 | $6 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
77 | $123 | $280 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
76 | $21 | $74 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
75 | $30 | $110 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
72 | $26 | $108 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
68 | $20 | $50 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
65 | $17 | $100 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
65 | $21 | $140 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
62 | $650 | $1,300 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
58 | $131 | $624 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
57 | $53 | $305 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
42 | $20 | $74 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
41 | $28 | $186 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
36 | $63 | $321 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
34 | $132 | $763 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
23 | $13 | $59 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
20 | $50 | $400 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
20 | $15 | $48 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $136 | $382 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
17 | $724 | $5,437 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
16 | $203 | $750 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
16 | $160 | $827 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $76 | $200 |
| Continuous ECG monitoring with symptom tracking, up to 30 days This procedure involves continuous electrocardiogram monitoring for up to 30 days. It includes symptom monitoring to correlate heart activity with patient-reported events. |
15 | $6 | $75 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
13 | $10 | $37 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
12 | $8 | $90 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $27 | $136 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $44 | $155 |
| Cardiac catheterization | 11 | $223 | $1,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.7% high complexity
17.1% medium
62.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,499
Total received (2018-2024)
Avg $357/year across 7 years
Bottom 35% in TX for cardiovascular disease
26
Companies
129
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,419 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$79 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$514
2023
$443
2022
$445
2021
$285
2020
$142
2019
$330
2018
$341
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$644
Merck Sharp & Dohme LLC
$271
PFIZER INC.
$220
Cleerly, Inc.
$195
AstraZeneca Pharmaceuticals LP
$155
Gilead Sciences, Inc.
$121
Boston Scientific Corporation
$89
Inspire Medical Systems, Inc.
$82
Janssen Pharmaceuticals, Inc
$75
Kiniksa Pharmaceuticals, Ltd.
$66
Tactile Systems Technology Inc
$65
Novartis Pharmaceuticals Corporation
$61
SANOFI-AVENTIS U.S. LLC
$61
E.R. Squibb & Sons, L.L.C.
$59
Medtronic Vascular, Inc.
$58
Medtronic, Inc.
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
SCPHARMACEUTICALS INC.
$41
CARDIVA MEDICAL, INC.
$36
Philips North America LLC
$26
Kiniksa Pharmaceuticals International, plc
$24
Kowa Pharmaceuticals America, Inc.
$13
Cardinal Health 200, LLC
$13
Merck Sharp & Dohme Corporation
$13
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$13
Amgen Inc.
$11
Top 3 companies account for 45.4% of total payments
Associated products mentioned in payments ›
(CK4) MCOT · Arcalyst · Assurity Pacemaker · BRILINTA · BodyGuardian · CHANTIX · Cleerly Ischemia · Confirm Rx · Corlanor · ELIQUIS · ENSITE PRECISION · ENTRESTO · FARXIGA · FFRANGIO · FUROSCIX · Flexitouch Plus · INSPIRE · JARDIANCE · JOT DX · LEQVIO · LifeVest · Livalo · MULTAQ · Mozec NC PTCA Balloon · REVEAL LINQ · Resolute · VERQUVO · VYNDAQEL · Vascular Closure Device · WATCHMAN Access System · XARELTO · Xience Sierra Coronary Stent
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $45 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
109
Per 100K population
5.1
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL ALLIANCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dodla is a remote & cardiac specialist, with above-average Medicare volume (top 13% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dodla experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Dodla performed 793 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dodla receive payments from pharmaceutical companies?
Yes. Dr. Dodla received a total of $2,499 from 26 companies across 129 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dodla's costs compare to other cardiologists in Fort Worth?
Dr. Dodla's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dodla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Fort Worth
Browse cardiologists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology